Evidence map›Paper›PMID 41503104›Full record

ArticleArXiv2025

Computational Analysis of Disease Progression in Pediatric Pulmonary Arterial Hypertension.

Omar Said, Christopher Tossas-Betancourt, Mary K Olive, Jimmy C Lu, Adam Dorfman, C Alberto Figueroa

Abstract readPreprint
In one paragraph

Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Omar SaidDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
Christopher Tossas-BetancourtDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
Mary K OliveDepartment of Pediatrics, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, MI, USA.
Jimmy C LuDepartment of Pediatrics, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, MI, USA.
Adam DorfmanDepartment of Pediatrics, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, MI, USA.
C Alberto FigueroaDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.

Funding

Image-based Multi-scale Modeling Framework of the Cardiopulmonary System: Longitudinal Calibration and Assessment of Therapies in Pediatric Pulmonary HypertensionU01HL135842 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BAEK, SEUNGIK, DORFMAN, ADAM LEE · 2017 to 2020
$2.3M
NHLBI NIH HHS U01 HL135842
6 · The paper itself

Abstract

Pulmonary arterial hypertension (PAH) is a progressive cardiopulmonary disease that leads to increased pulmonary pressures, vascular remodeling, and eventual right ventricular (RV) failure. Pediatric PAH remains understudied due to limited data and the lack of targeted diagnostic and therapeutic strategies. In this study, we developed and calibrated multi-scale, patient-specific cardiovascular models for four pediatric PAH patients using longitudinal MRI and catheterization data collected approximately two years apart. Using the CRIMSON simulation framework, we coupled three-dimensional fluid-structure interaction (FSI) models of the pulmonary arteries with zero-dimensional (0D) lumped-parameter heart and Windkessel models to simulate patient hemodynamics. An automated Python-based optimizer was developed to calibrate boundary conditions by minimizing discrepancies between simulated and clinical metrics, reducing calibration time from weeks to days. Model-derived metrics such as arterial stiffness, pulse wave velocity, resistance, and compliance were found to align with clinical indicators of disease severity and progression. Our findings demonstrate that computational modeling can non-invasively capture patient-specific hemodynamic adaptation over time, offering a promising tool for monitoring pediatric PAH and informing future treatment strategies.

Identifiers

PMID41503104
PMCPMC12772708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.